452 related articles for article (PubMed ID: 18636150)
1. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
2. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
[TBL] [Abstract][Full Text] [Related]
5. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
7. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
[TBL] [Abstract][Full Text] [Related]
8. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
9. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
11. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
12. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
Ludwig A; Schulte A; Schnack C; Hundhausen C; Reiss K; Brodway N; Held-Feindt J; Mentlein R
J Neurochem; 2005 Jun; 93(5):1293-303. PubMed ID: 15934948
[TBL] [Abstract][Full Text] [Related]
14. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner.
Huang Y; Zhu XY; Du MR; Wu X; Wang MY; Li DJ
Hum Reprod; 2006 Apr; 21(4):1083-91. PubMed ID: 16431903
[TBL] [Abstract][Full Text] [Related]
15. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
16. Loss of ONECUT1 expression in human pancreatic cancer cells.
Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
[TBL] [Abstract][Full Text] [Related]
17. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues.
Manabe S; Iwase A; Goto M; Kobayashi H; Takikawa S; Nagatomo Y; Nakahara T; Bayasula ; Nakamura T; Hirokawa W; Kikkawa F
Arch Gynecol Obstet; 2011 Dec; 284(6):1567-72. PubMed ID: 21773780
[TBL] [Abstract][Full Text] [Related]
19. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
